ArticleQatar medical journal2025

Fasting during Ramadan is associated with changes in activity and blood glucose excursion in people with type 2 diabetes on three or more anti-hyperglycemic agents PROFAST-3.

Mohammed Bashir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.